Sirnaomics Ltd.

Research Sirnaomics Ltd. (V5Z) on Bullrun: market cap EUR 58.67M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerV5Z
• ExchangeF
• CountryHong Kong
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 58.67M
• Financial periodFY2024
• RevenueEUR 1.78M
• Net income-EUR 51.38M
• Free cash flow-EUR 19.84M
• Gross margin67.4%

Valuation Snapshot

latest market cap is EUR 58.67M.

About Sirnaomics Ltd.

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People's Republic of China. The company's therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates comprising STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; STP369 to treat head and neck cancer;

Frequently asked questions

What is Sirnaomics Ltd.'s market cap?

Sirnaomics Ltd.'s market capitalization is EUR 58.67M.

What does Sirnaomics Ltd. do?

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People's Republic of China.